An Evaluation of the WHO QUAlityRights Program (EQUAR)

December 3, 2025 updated by: GCS-CCOMS

The World Health Organization's (WHO) QualityRights (QR) program offers assessments and recommendations to help mental health facilities, on a voluntary basis, improve their care practices towards better respect of the rights of service users. The aim of this study is to evaluate the QR program in a French national context.

The main questions it aims to answer are:

  • Does the QR program improve perceived satisfaction with care among mental health service users?
  • What are the implementation procedures of the program?
  • What is its budgetary impact?

Researchers will compare the QR program intervention with usual practices.

Study Overview

Detailed Description

In France, despite the existence of recommendations and a restrictive legal framework, the use of restraint practices in psychiatry remains widespread, and the duration and conditions of hospitalization do not always guarantee respect for users' rights.

The World Health Organization's (WHO) QualityRights (QR) program offers assessments, called "observations", and recommendations to help mental health facilities, on a voluntary basis, improve their care practices towards better respect of the rights of service users. However, the program has never been evaluated in a French national context.

The WHO QR program, published in 2012 and regularly updated since, aims to improve the quality of care in mental health and related services and promote the rights of people with psychosocial, intellectual and cognitive disabilities.

The reference base for the tools that make up the program is the United Nations Convention on the Rights of Persons with Disabilities (CRPD), ratified by France in 2010. This international convention defines ambitious objectives in terms of respect for rights, some of which are particularly relevant to mental health services. However, the convention does not offer any concrete indications as to how these major international standards are to be applied.

The QR program provides a concrete response to this need, offering observation and training tools not only for mental health services, but more broadly for all those concerned by mental health issues. In particular, the observation methodology is designed to respond to a request for support in changing practices that comes directly from a facility.

The WHO Collaborating Centre in Lille is mandated by the WHO to roll out this program in France and other French-speaking countries. It is expected that the QualityRights approach will act as a lever for change in the organization of services, providing a multidisciplinary perspective on users' rights and recovery-oriented practices.

The primary research objective is to evaluate the effectiveness of the QR program on the perceived satisfaction with care of mental health service users.

The secondary research objectives concern:

A. Evaluating the effectiveness of the QR program on:

  1. Improving work-related quality of life among mental health professionals
  2. Decreasing the number of involuntary admissions
  3. Reducing the length of full-time hospital stays
  4. Reducing the number of acts of seclusion and restraint
  5. The distribution of clinical activity in favour of ambulatory activity

B. Evaluating the efficiency and the budgetary impact of the QR program.

C. Conducting an implementation study to understand the appropriation of the recommendations by professionals and management following the introduction of the QR program by exploring the representations linked to the QR program and respect for users' rights among mental health professionals.

This research involves an effectiveness study, supplemented by an implementation study based on a qualitative methodology, and an economic evaluation.

The effectiveness study is a cluster randomized trial designed to compare the effectiveness of the QR program intervention versus usual practices on user satisfaction. The cluster is defined at the level of the psychiatric sector (the public psychiatric care entity organizing the mental health care of a population within a pre-specified geographical and demographic area in France, to meet local needs). 10 psychiatric sectors are participating, randomized into two groups: the intervention group receiving the QR program and the control group maintaining their usual practices.

Data will be collected in both groups at baseline, and during follow-up at 1 and 2 years. The implementation study and the economic evaluation will be carried out in the intervention group after the effectiveness study.

Study Type

Interventional

Enrollment (Estimated)

1800

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Armentières, France, 59280
        • Public mental health establishment of Lille Metropole (59G09/G10)
      • Armentières, France, 59280
        • Public mental health establishment of Lille Metropole (59G20)
      • Erstein, France, 67150
        • Hospital Centre of Erstein
      • Laxou, France, 54520
        • Psychotherapeutic Center of Nancy
      • Montéléger, France, 26760
        • Hospital Centre Drôme Vivarais
      • Nanterre, France, 92014
        • Hospital Care Center of Nanterre
      • Nice, France, 06100
        • Hospital Centre Sainte-Marie Nice
      • Plaisir, France, 78370
        • Hospital Center of Plaisir (78G16)
      • Plaisir, France, 78370
        • Hospital Center of Plaisir (78G18)
      • Pont-du-Casse, France, 47480
        • Hospital Center of Candélie

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adults (18 years or older)
  • Persons having formulated a non-opposition to participate in the study
  • Population a (users): Service users of the psychiatric sectors involved in the study hospitalized full-time since at least 3 days in an inpatient unit.
  • Population b (professionals): Mental health professionals working in the sector since at least 3 months at the time of study participation

Exclusion Criteria:

  • Persons physically or psychologically unable to participate at the time of the study
  • Persons subject to a safeguard of justice measure
  • Persons who do not speak or understand the French language

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Sectors receiving the WHO QualityRights program

The WHO's QualityRights program involves an assessment, called observation, of mental health care services by an ephemeral multidisciplinary team, which provides feedback and recommendations for improving care practices. The observation team, trained in the QualityRights (QR) methodology, includes mental health professionals, researchers, legal experts, and management staff from mental health organizations. Each team always incorporates at least one expert by experience and one informal caregiver or family member. Participation in the program is voluntary and initiated at the request of healthcare facilities.

The observation is structured into three stages:

  1. Site preparation
  2. On-site observation
  3. Restitution of observation report and follow-up
No Intervention: Usual practices
Sectors not receiving the WHO QualityRights program, and maintaining usual practices

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Satisfaction with care
Time Frame: At baseline, at 1 year, and at 2 years
Service user satisfaction with care score assessed using the Verona Service Satisfaction Scale (VSSS-54F)
At baseline, at 1 year, and at 2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Work-related quality of life
Time Frame: At baseline, at 1 year, and at 2 years
Work-related quality of life score for mental health professionals assessed using the SERENAT scale
At baseline, at 1 year, and at 2 years
Involuntary psychiatric hospitalisations
Time Frame: At baseline, at 1 year, and at 2 years
Number of involuntary hospitalizations in the 6 months preceding the time point
At baseline, at 1 year, and at 2 years
Length of stay
Time Frame: At baseline, at 1 year, and at 2 years
Length of stay for each patient in the 6 months preceding the time points
At baseline, at 1 year, and at 2 years
Seclusion and restraint
Time Frame: At baseline, at 1 year, and at 2 years
Number of acts of seclusion and restraint in the 6 months preceding the time points
At baseline, at 1 year, and at 2 years
Distribution of hospital activity
Time Frame: At baseline, at 1 year, and at 2 years
Hospital case load and outpatient service utilization in the 6 months preceding the time points
At baseline, at 1 year, and at 2 years
Cost-utility
Time Frame: 24 months
Incremental cost-utility ratio in cost per QALY gained (EQ-5D-5L questionnaire)
24 months
Cost-effectiveness
Time Frame: 24 months
Incremental cost-effectiveness ratio in cost per VSSS-54F score points gained
24 months
Budgetary impact - costs
Time Frame: 5 years after hypothetical generalization
Costs associated with the generalization of the QR program
5 years after hypothetical generalization
Budgetary impact - QALY
Time Frame: 5 years after hypothetical generalization
The number of QALYs will be calculated with and without the QR program to assess the gains associated with its generalization.
5 years after hypothetical generalization
Budgetary impact - Involuntary psychiatric hospitalizations
Time Frame: 5 years after hypothetical generalization
The number of involuntary hospitalizations will be calculated with and without the QR program to assess the gains associated with its generalization.
5 years after hypothetical generalization
Budgetary impact - Length of stay
Time Frame: 5 years after hypothetical generalization
The length of stay will be calculated with and without the QR program to assess the gains associated with its generalization.
5 years after hypothetical generalization
Budgetary impact - Seclusion and restraint
Time Frame: 5 years after hypothetical generalization
The number of acts of seclusion and restraint will be calculated with and without the QR program to assess the gains associated with its generalization.
5 years after hypothetical generalization
Implementation
Time Frame: In the 1 year following the last time point
Qualitative methods will be used through semi-structured interviews conducted with 10 mental health professionals per sector of the intervention group.
In the 1 year following the last time point

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Chair: Déborah Sebbane, MD, PhD, GCS-CCOMS & ECEVE 1123 INSERM

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 17, 2024

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

October 1, 2027

Study Registration Dates

First Submitted

February 20, 2025

First Submitted That Met QC Criteria

March 7, 2025

First Posted (Actual)

March 13, 2025

Study Record Updates

Last Update Posted (Estimated)

December 4, 2025

Last Update Submitted That Met QC Criteria

December 3, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2024-A00092-45
  • PREPS-22-0042 (Other Grant/Funding Number: French Ministry of Health)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Recovery

Clinical Trials on WHO QualityRights program

Subscribe